PRESS RELEASE
24 September 2026

Advising Futura Medical Plc On Its Fundraise And Launch Of Formal Sale Process

WT
Winston Taylor

Contributor

Whether you're leading the way, disrupting an industry, entering a new phase of growth, or launching a defining product—we're in the room with you. In the action. Sleeves rolled up.

With a rich history spanning both sides of the Atlantic, we are present in the major commercial centers that matter to our clients: the U.S., the U.K., Europe, Latin America, and the Middle East. Combining scale with the speed clients demand, our defining capabilities include major litigation, critical transactions, strategic IP, and private wealth.

Our team of over 1,400 lawyers works hand-in-hand across markets, sectors, practice areas, and client teams. All-in problem solvers, we bring the creativity to think differently, and the pragmatism to get things done when it counts the most.

Embedded in your business and sharing your ambition, we take the work personally. Shaping what we do and how we do it around your goals and needs, always one step ahead of the moment.

Winston Taylor advises Futura Medical, the consumer healthcare group behind Eroxon®, on a GBP1.8 million equity fundraise and the launch of both an M&A Process and Formal Sale Process under the Takeover Code.
United Kingdom

Futura Medical has come to us for support on its equity fundraising and the launch of an M&A and Formal Sale Process, drawing on our life sciences sector, equity capital markets and public M&A and transactions experience.

We are advising Futura Medical, the consumer healthcare group behind Eroxon® that specializes in the development and global commercialization of innovative and clinically proven sexual health products, on its equity fundraise of approximately GBP1.8 million, including a separate retail offer via the BookBuild platform, and on the Company's launch of an M&A Process and a Formal Sale Process in accordance with the Takeover Code.

Completion of the fundraise is expected to provide cash resources into February 2027, which would allow Futura Medical to explore the M&A Process and the Formal Sale Process and continue executing on its strategy in the near term.

Our team was led by Andrew Edge and Rebecca Jack, with support from Nuria Ashmore Barrios, Ellie Cooper, and Amy Hughes in the Corporate Team.

Contributor

Whether you're leading the way, disrupting an industry, entering a new phase of growth, or launching a defining product—we're in the room with you. In the action. Sleeves rolled up.

With a rich history spanning both sides of the Atlantic, we are present in the major commercial centers that matter to our clients: the U.S., the U.K., Europe, Latin America, and the Middle East. Combining scale with the speed clients demand, our defining capabilities include major litigation, critical transactions, strategic IP, and private wealth.

Our team of over 1,400 lawyers works hand-in-hand across markets, sectors, practice areas, and client teams. All-in problem solvers, we bring the creativity to think differently, and the pragmatism to get things done when it counts the most.

Embedded in your business and sharing your ambition, we take the work personally. Shaping what we do and how we do it around your goals and needs, always one step ahead of the moment.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More